Thomas Michael Marti
Thomas Michael Marti
University Hospital Bern
Verified email at
Cited by
Cited by
H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks
TM Marti, E Hefner, L Feeney, V Natale, JE Cleaver
Proceedings of the National Academy of Sciences 103 (26), 9891-9896, 2006
DNA mismatch repair and mutation avoidance pathways
TM Marti, C Kunz, O Fleck
Journal of cellular physiology 191 (1), 28-41, 2002
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Y Shi, E Felley-Bosco, TM Marti, K Orlowski, M Pruschy, RA Stahel
BMC cancer 12, 1-10, 2012
A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids
J Ruppen, L Cortes-Dericks, E Marconi, G Karoubi, RA Schmid, R Peng, ...
Lab on a Chip 14 (6), 1198-1205, 2014
DNA repair nucleases
TM Marti, O Fleck
Cellular and Molecular Life Sciences CMLS 61, 336-354, 2004
Translesion DNA synthesis in the context of cancer research
PA Knobel, TM Marti
Cancer cell international 11, 1-19, 2011
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
SQ Liang, TM Marti, P Dorn, L Froment, SRR Hall, S Berezowska, ...
Cell death & disease 6 (7), e1824-e1824, 2015
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
LL Belyanskaya, TM Marti, S Hopkins-Donaldson, S Kurtz, E Felley-Bosco, ...
Molecular cancer 6, 1-13, 2007
Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells
PA Knobel, IN Kotov, E Felley-Bosco, RA Stahel, TM Marti
Neoplasia 13 (10), 961-IN28, 2011
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer
H Yang, SQ Liang, D Xu, Z Yang, TM Marti, Y Gao, GJ Kocher, H Zhao, ...
Oncogenesis 8 (9), 45, 2019
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
SQ Liang, ED Bührer, S Berezowska, TM Marti, D Xu, L Froment, H Yang, ...
Oncogene 38 (5), 622-636, 2019
Pol η is required for DNA replication during nucleotide deprivation by hydroxyurea
S De Feraudy, CL Limoli, E Giedzinski, D Karentz, TM Marti, L Feeney, ...
Oncogene 26 (39), 5713-5721, 2007
Tumor initiation capacity and therapy resistance are differential features of EMT-related subpopulations in the NSCLC cell line A549
CC Tièche, Y Gao, ED Bührer, N Hobi, SA Berezowska, K Wyler, ...
Neoplasia 21 (2), 185-196, 2019
Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro
S Zeinali, CA Bichsel, N Hobi, M Funke, TM Marti, RA Schmid, OT Guenat, ...
Angiogenesis 21, 861-871, 2018
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA. 1 phenotype
GT Barut, NJ Halwe, A Taddeo, JN Kelly, J Schön, N Ebert, L Ulrich, ...
Nature Communications 13 (1), 5929, 2022
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
CC Tièche, RW Peng, P Dorn, L Froment, RA Schmid, TM Marti
BMC cancer 16, 1-15, 2016
Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model
CA Bichsel, L Wang, L Froment, S Berezowska, S Müller, P Dorn, ...
Scientific reports 7 (1), 10636, 2017
Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma
H Yang, B Sun, L Fan, W Ma, K Xu, SRR Hall, Z Wang, RA Schmid, ...
Theranostics 12 (7), 3104, 2022
Endoplasmic reticulum stress signaling as a therapeutic target in malignant pleural mesothelioma
D Xu, H Yang, Z Yang, S Berezowska, Y Gao, SQ Liang, TM Marti, ...
Cancers 11 (10), 1502, 2019
CRISPR screening identifies WEE1 as a combination target for standard chemotherapy in malignant pleural mesothelioma
D Xu, SQ Liang, H Yang, R Bruggmann, S Berezowska, Z Yang, TM Marti, ...
Molecular cancer therapeutics 19 (2), 661-672, 2020
The system can't perform the operation now. Try again later.
Articles 1–20